3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Phase 2
1
Status
Terminated
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Classical hematology
3
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Gastrointestinal
1
Conditions
Venous Thromboembolism
11
Venous Thrombosis
4
Neoplasms
4
Thrombosis
3
Pulmonary Embolism
3
Thrombocytopenia
1
Sarcoma
1
Multiple Myeloma
1
Lymphoma
1
Leukemia
1
Hematoma
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Bone Neoplasms
1
Abdominal Neoplasms
1
Interventions
Dalteparin
9
apixaban
6
Heparin, Low-Molecular-Weight
3
Enoxaparin
3
edoxaban
2
abelacimab
2
Tinzaparin
2
Rivaroxaban
2
MAA868
2
Dabigatran
2
isoquercitrin
1
enoxaparin sodium
1
bemiparin
1
Warfarin
1
Rosuvastatin Calcium
1
Fondaparinux
1
Educational Status
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Pulmonary Embolism
×
Enoxaparin
×
Classical hematology
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled
NCT02744092
2023-10-03
CANVAS
Alliance Foundation Trials, LLC.
Phase NA
Completed
811 enrolled
19 charts
NCT01817257
2018-10-29
ALICAT
Cardiff University
Phase 2
Terminated
2 enrolled